Peter Mueller

Insider Reports History

Entity
Individual
Signature
/s/ Richard I. Steinhart, Attorney-in-Fact for Peter Mueller
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter Mueller:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BioXcel Therapeutics, Inc. Director Stock Option (Right to Buy) 17K Jun 10, 2024 Direct

Insider Reports Filed by Peter Mueller

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BTAI BioXcel Therapeutics, Inc. Jun 10, 2024 1 $0 4 Jun 11, 2024 Director
BTAI BioXcel Therapeutics, Inc. Jun 26, 2023 1 $0 4 Jun 28, 2023 Director
BTAI BioXcel Therapeutics, Inc. May 19, 2022 1 $0 4 May 23, 2022 Director
BTAI BioXcel Therapeutics, Inc. Jun 11, 2021 1 $0 4 Jun 15, 2021 Director